Lord, Abbett & Co
LBPH

Lord, Abbett & Co’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Lord, Abbett & Co’s Portfolio LBPH Stock Details LBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-626,905
Closed -$20.9M – 599
2024
Q3 		$20.9M Buy
626,905
+164,795
+36% +$5.67M 0.07% 328
2024
Q2 		$12.5M Sell
462,110
-13,069
-3% -$258K 0.04% 370
2024
Q1 		$10.3M Buy
+475,179
New +$10.4M 0.03% 396

Lord, Abbett & Co's LBPH Position: Q4 2024 in Review

Lord, Abbett & Co sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 626,905 shares — an estimated $20.9M sold.

Lord, Abbett & Co first reported a position in LBPH in Q1 2024 and held it in 3 quarters. The position peaked at $20.9M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

  • Lord, Abbett & Co reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Lord, Abbett & Co sold 626,905 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $20.9M.
  • Lord, Abbett & Co first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
  • Lord, Abbett & Co's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $20.9M in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Lord, Abbett & Co's 13F filing for Q4 2024, filed 14 Feb 2025.